Toronto - Delayed Quote CAD

Medical Facilities Corporation (DR.TO)

Compare
15.46 +0.26 (+1.71%)
At close: January 7 at 3:59:40 PM EST
Loading Chart for DR.TO
DELL
  • Previous Close 15.20
  • Open 15.01
  • Bid 15.41 x --
  • Ask 15.49 x --
  • Day's Range 15.01 - 15.51
  • 52 Week Range 8.84 - 16.70
  • Volume 35,659
  • Avg. Volume 48,319
  • Market Cap (intraday) 361.745M
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 13.56
  • EPS (TTM) 1.14
  • Earnings Date Mar 12, 2025 - Mar 17, 2025
  • Forward Dividend & Yield 0.36 (2.37%)
  • Ex-Dividend Date Dec 31, 2024
  • 1y Target Est 16.61

Medical Facilities Corporation, through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States. The company's specialty hospital offers non-emergency surgical, imaging, diagnostic, and pain management procedures, as well as other ancillary services, such as primary and urgent care; and ambulatory surgery centers offers scheduled outpatient surgical procedures. Medical Facilities Corporation was incorporated in 2004 and is headquartered in Toronto, Canada.

www.medicalfacilitiescorp.ca

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DR.TO

View More

Performance Overview: DR.TO

Trailing total returns as of 1/7/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

DR.TO
1.05%
S&P/TSX Composite index
1.26%

1-Year Return

DR.TO
79.14%
S&P/TSX Composite index
19.07%

3-Year Return

DR.TO
86.41%
S&P/TSX Composite index
18.31%

5-Year Return

DR.TO
314.93%
S&P/TSX Composite index
45.74%

Compare To: DR.TO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DR.TO

View More

Valuation Measures

As of 1/6/2025
  • Market Cap

    355.66M

  • Enterprise Value

    469.44M

  • Trailing P/E

    13.32

  • Forward P/E

    19.19

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.58

  • Price/Book (mrq)

    3.18

  • Enterprise Value/Revenue

    0.74

  • Enterprise Value/EBITDA

    3.06

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.43%

  • Return on Assets (ttm)

    13.60%

  • Return on Equity (ttm)

    48.07%

  • Revenue (ttm)

    441.27M

  • Net Income Avi to Common (ttm)

    19.53M

  • Diluted EPS (ttm)

    1.14

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    18.67M

  • Total Debt/Equity (mrq)

    86.99%

  • Levered Free Cash Flow (ttm)

    44.7M

Research Analysis: DR.TO

View More

People Also Watch